Table 3.
Cytokine | Brain interstitial fluid |
Serum |
||||||
---|---|---|---|---|---|---|---|---|
Slope | p value | Lowera | Upperb | Slope | p value | Lowera | Upperb | |
IL-8 | −0.013 | 0.002 | −0.02 | −0.006 | 0.006 | 0.054 | 0 | 0.012 |
IP-10 | −0.009 | 0.014 | −0.016 | −0.002 | −0.001 | 0.245 | −0.003 | 0.001 |
MCP-1 | −0.014 | <0.001 | −0.02 | −0.008 | 0 | 0.557 | −0.001 | 0.002 |
MIP-1β | −0.013 | <0.001 | −0.018 | −0.008 | −0.001 | 0.029 | −0.002 | 0 |
IL-6c | −0.013 | 0.002 | −0.02 | −0.006 | 0.065, 0.013 | 0.004 | 0.03 | 0.1 |
0.01 | −0.02 | −0.005 | ||||||
IL12p40p70 | −0.015 | 0.026 | −0.027 | −0.002 | 0 | 0.573 | 0 | 0.001 |
IL-1RA | −0.005 | 0.073 | −0.01 | 0.001 | −0.001 | 0.493 | −0.003 | 0.002 |
MIP-1α | −0.013 | 0.002 | −0.02 | −0.006 | 0.001 | 0.429 | −0.002 | 0.005 |
RANTES | −0.015 | 0.101 | −0.034 | 0.004 | −0.005 | 0.400 | −0.02 | 0.01 |
IFN-α | −0.01 | 0.043 | −0.02 | 0 | 0.001 | 0.109 | 0 | 0.002 |
G-CSF | −0.021 | 0.049 | −0.042 | 0 | −0.001 | 0.452 | −0.004 | 0.002 |
IL-2R | −0.025 | 0.044 | −0.05 | −0.001 | 0 | 0.808 | −0.001 | 0.001 |
VEGF | −0.005 | 0.002 | −0.007 | −0.003 | 0 | 0.761 | −0.004 | 0.005 |
IL-17 | −0.008 | 0.110 | −0.019 | 0.003 | −0.001 | 0.367 | −0.003 | 0.001 |
IL-10 | −0.006 | 0.145 | −0.016 | 0.003 | −0.003 | 0.185 | −0.009 | 0.002 |
MIG | −0.014 | 0.215 | −0.04 | 0.012 | −0.003 | 0.164 | −0.007 | 0.003 |
IFN-γ | −0.013 | 0.264 | −0.037 | 0.012 | 0.01 | 0.411 | −0.002 | 0.003 |
n/a Insufficient patient data (n<2) for analysis
Lower boundary for the 95 % confidence interval
Upper boundary for the 95 % confidence interval
For IL-6 serum only, the results are presented for the two-phase linear regression. The first row represents 0–12 h, and the second row represents 12–96 h. The p values and 95 % confidence intervals of the slopes of the two lines are presented